A retrospective study analysing associated health care resource use and costs in first salvage therapy for AML
Latest Information Update: 02 Feb 2022
At a glance
- Drugs Gilteritinib (Primary) ; Antineoplastics; Protein tyrosine kinase inhibitors; Venetoclax
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 02 Feb 2022 New trial record
- 14 Dec 2021 Results presented at the 63rd American Society of Hematology Annual Meeting and Exposition